Pathogenicity and virulence of henipaviruses

References

• Wong KT, Shieh WJ, Zaki SR, et al. Nipah virus infection, an emerging paramyxoviral zoonosis. Springer Semin Immunopathol. 2002;24(2):215–17. doi: 10.1007/s00281-002-0106-y
   PubMed Web of Science ®Google Scholar
• Escaffre O, Borisevich V, Rockx B. Pathogenesis of Hendra and Nipah virus infection in humans. J Infect Dev Ctries. 2013;7(4):308–311. doi: 10.3855/jidc.3648
   PubMed Web of Science ®Google Scholar
• Zhang, Xiao-Ai , Li, HaoJiang, Fa-Chun, et al. A zoonotic henipavirus in febrile patients in China. 2022. doi: 10.1056/NEJMc2202705
   Google Scholar
• Wu Z, Yang L, Yang F, et al. Novel henipa-like virus, Mojiang Paramyxovirus, in rats, China, 2012. Emerg Infect Dis. 2014;20(6):1064–1066. doi: 10.3201/EID2006.131022
   PubMed Web of Science ®Google Scholar
• Croser EL, Marsh GA. The changing face of the henipaviruses. Vet Microbiol. 2013;167(1–2):151–158. doi: 10.1016/j.vetmic.2013.08.002
   PubMed Web of Science ®Google Scholar
• Madera S, Kistler A, Ranaivoson HC, et al. Discovery and genomic characterization of a novel henipavirus, angavokely virus, from fruit bats in Madagascar. J Virol. 2022;96(18). doi: 10.1128/jvi.00921-22
   PubMed Web of Science ®Google Scholar
• Marsh GA, de Jong C, Barr JA, et al. Cedar virus: a novel henipavirus isolated from Australian bats. PLOS Pathog. 2012;8(8). doi: 10.1371/JOURNAL.PPAT.1002836
   Web of Science ®Google Scholar
• Weiss S, Nowak K, Fahr J, et al. Henipavirus-related sequences in fruit bat bushmeat, Republic of Congo. Emerg Infect Dis. 2012;18(9):1536–1537. doi: 10.3201/eid1809.111607
   PubMed Web of Science ®Google Scholar
• Hernández LHA, da Paz TYB, da SS, et al. First Genomic Evidence of a Henipa-like Virus in Brazil. Viruses. 2022;14(10):2167. doi: 10.3390/V14102167
   PubMed Web of Science ®Google Scholar
• Pernet O, Schneider BS, Beaty SM, et al. Evidence for henipavirus spillover into human populations in Africa. Nat Commun. 2014;5(1):5. doi: 10.1038/ncomms6342
   Google Scholar
• Vanmechelen B, Meurs S, Horemans M, et al. The characterization of multiple novel paramyxoviruses highlights the diverse nature of the subfamily orthoparamyxovirinae. Virus Evol. 2022 Jun 30;veac061. doi: 10.1093/ve/veac061. PMID: 35854826; PMCID: PMC9290864.
   Google Scholar
• Field HE, Barratt PC, Hughes RJ, et al. A fatal case of Hendra virus infection in a horse in north Queensland: clinical and epidemiological features. Aust Vet J. 2000;78(4):279–280. doi: 10.1111/J.1751-0813.2000.TB11758.X
   PubMed Web of Science ®Google Scholar
• Taylor J, Thompson K, Annand EJ, et al. Novel variant Hendra virus genotype 2 infection in a horse in the greater Newcastle region. New South Wales:Australia. One Health. 2022; 15. doi: 10.1016/j.onehlt.2022.100423
   Google Scholar
• Williamson MM, Hooper PT, Selleck PW, et al. Experimental Hendra virus infection in pregnant guinea-pigs and fruit bats (Pteropus poliocephalus). J Comput Pathol. 2000;122(2–3):201–207. doi: 10.1053/jcpa.1999.0364
   PubMed Web of Science ®Google Scholar
• Williamson MM, Hooper PT, Selleck PW, et al. Transmission studies of Hendra virus (equine morbillivirus) in fruit bats, horses and cats. Aust Vet J. 1998;76(12):813–818. doi: 10.1111/J.1751-0813.1998.TB12335.X
   PubMed Web of Science ®Google Scholar
• Hooper PT, Gould AR, Hyatt AD, et al. Identification and molecular characterisation of Hendra virus in a horse in Queensland. Aust Vet J. 2000;78(4):281–282. doi: 10.1111/J.1751-0813.2000.TB11759.X
   PubMed Web of Science ®Google Scholar
• Hooper P, Zaki S, Daniels P, et al. Comparative pathology of the diseases caused by Hendra and Nipah viruses. Microbes Infect. 2001;3(4):315–322. doi: 10.1016/S1286-4579(01)01385-5
   PubMed Web of Science ®Google Scholar
• Field H, Young P, Yob JM, et al. The natural history of Hendra and Nipah viruses. Microbes Infect. 2001;3(4):307–314. doi: 10.1016/S1286-4579(01)01384-3
   PubMed Web of Science ®Google Scholar
• Halpin K, Young PL, Field HE, et al. Isolation of Hendra virus from pteropid bats: a natural reservoir of Hendra virus. J Gen Virol. 2000;81(8):1927–1932. doi: 10.1099/0022-1317-81-8-1927
   PubMed Web of Science ®Google Scholar
• Outbreak of Hendra-like virus—Malaysia and Singapore, 1998–1999. CDC Surveillance Summary. 1999;48:265–268.
   Google Scholar
• Talukdar P, Dutta D, Ghosh E, et al. Molecular Pathogenesis of Nipah Virus. Appl Biochem Biotechnol. 2023;195(4):2451–2462. Published online 2023. doi: 10.1007/s12010-022-04300-0
   PubMed Web of Science ®Google Scholar
• Chua KB, Goh KJ, Wong KT, et al. Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet. 1999;354(9186):1257–1259. doi: 10.1016/S0140-6736(99)04299-3
   PubMed Web of Science ®Google Scholar
• Enserink M. Emerging diseases: Malaysian researchers trace Nipah virus outbreak to bats. Sci (1979). 2000;289(5479):518–519. doi: 10.1126/science.289.5479.518
   Web of Science ®Google Scholar
• Chua KB. Nipah virus outbreak in Malaysia. J Clin Virol. 2003;26(3):265–275. doi: 10.1016/S1386-6532(02)00268-8
   PubMed Web of Science ®Google Scholar
• KB C, WJ B, PA R, et al. Nipah virus: a recently emergent deadly paramyxovirus. Science. 2000;288(5470):1432–1435. doi: 10.1126/SCIENCE.288.5470.1432
   PubMed Web of Science ®Google Scholar
• Paola KG, Ching VCde L, Alah Baby R, et al. Outbreak of Henipavirus Infection, Philippines, 2014. [accessed 2023 March 30]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4313660/pdf/14-1433.pdf
   Google Scholar
• Chakraborty A, Sazzad HMS, Hossain MJ, et al. Evolving epidemiology of Nipah virus infection in Bangladesh: evidence from outbreaks during 2010–2011. Epidemiol Infect. 2016;144(2):371–380. doi: 10.1017/S0950268815001314
   PubMed Web of Science ®Google Scholar
• Banerjee S, Gupta N, Kodan P, et al. Nipah virus disease: A rare and intractable disease. Intractable Rare Dis Res. 2019;8(1):1–8. doi: 10.5582/IRDR.2018.01130
   PubMed Web of Science ®Google Scholar
• Nipah virus infection - Bangladesh. Accessed March. 30. 2023;https://www.who.int/emergencies/disease-outbreak-news/item/2023-DON442
   Google Scholar
• Shete AM, Radhakrishnan C, Pardeshi PG, et al. Antibody response in symptomatic & asymptomatic Nipah virus cases from Kerala, India. Indian J Med Res. 2021;154(3):533–535. doi: 10.4103/IJMR.IJMR_4388_20
   PubMed Web of Science ®Google Scholar
• Hegde ST, Sazzad HMS, Hossain MJ, et al. Investigating Rare Risk Factors for Nipah Virus in Bangladesh: 2001–2012. Ecohealth. 2016;13(4):720–728. doi: 10.1007/S10393-016-1166-0
   PubMed Web of Science ®Google Scholar
• Hossain MJ, Gurley ES, Montgomery JM, et al. Clinical presentation of nipah virus infection in Bangladesh. Clin Infect Dis. 2008;46(7):977–984. doi: 10.1086/529147
   PubMed Web of Science ®Google Scholar
• Marsh GA, de Jong C, Barr JA, et al. Cedar virus: a novel henipavirus isolated from Australian bats. PLOS Pathog. 2012;8(8):e1002836. doi: 10.1371/JOURNAL.PPAT.1002836
   PubMed Web of Science ®Google Scholar
• Schountz T, Campbell C, Wagner K, et al. Differential innate immune responses elicited by nipah virus and cedar virus correlate with disparate in vivo pathogenesis in hamsters. Viruses. 2019;11(3):291. doi: 10.3390/v11030291
   PubMed Web of Science ®Google Scholar
• Rissanen I, Ahmed AA, Azarm K, et al. Idiosyncratic mòjiāng virus attachment glycoprotein directs a host-cell entry pathway distinct from genetically related henipaviruses. Nat Commun. 2017;8(1):8. doi: 10.1038/NCOMMS16060
   PubMedGoogle Scholar
• Cheliout Da SS, Yan L, Dang HV, et al. Functional analysis of the fusion and attachment glycoproteins of mojiang henipavirus. Viruses. 2021;13(3). doi: 10.3390/v13030517
   Web of Science ®Google Scholar
• Mathieu C, Guillaume V, Volchkova VA, et al. Nonstructural Nipah virus C protein regulates both the early host proinflammatory response and viral virulence. J Virol. 2012;86(19):10766. doi: 10.1128/JVI.01203-12
   PubMed Web of Science ®Google Scholar
• Andrejeva J, Young DF, Goodbourn S, et al. Degradation of STAT1 and STAT2 by the V proteins of simian virus 5 and human parainfluenza virus type 2, respectively: consequences for virus replication in the presence of Alpha/Beta and Gamma Interferons. J Virol. 2002;76(5):2159–2167. doi: 10.1128/JVI.76.5.2159-2167.2002
   PubMed Web of Science ®Google Scholar
• Becker N, Maisner A. Nipah virus impairs autocrine IFN signaling by sequestering STAT1 and STAT2 into inclusion bodies. Viruses. 2023;15(2): doi: 10.3390/V15020554
   Web of Science ®Google Scholar
• Siering O, Cattaneo R, CK P. C proteins: controllers of Orderly paramyxovirus replication and of the innate immune response. Viruses. 2022;14(1):137. doi: 10.3390/v14010137
   PubMed Web of Science ®Google Scholar
• Lee SH, Kim K, Kim J, et al. Discovery and genetic characterization of novel paramyxoviruses related to the genus henipavirus in Crocidura species in the Republic of Korea. Viruses. 2021;13(10):2020. doi: 10.3390/V13102020
   PubMed Web of Science ®Google Scholar
• Roy A, Chan Mine E, Gaifas L, et al. Orthoparamyxovirinae C proteins have a common Origin and a common structural organization. Biomolecules. 2023;13(3):455. doi: 10.3390/BIOM13030455
   PubMed Web of Science ®Google Scholar
• Lo MK, Søgaard TM, Karlin DG, et al. Evolution and structural organization of the C proteins of paramyxovirinae. PLoS One. 2014;9(2):e90003. doi: 10.1371/journal.pone.0090003
   PubMed Web of Science ®Google Scholar
• Wignall-Fleming EB, Hughes DJ, Vattipally S, et al. Analysis of paramyxovirus transcription and replication by high-throughput sequencing. J Virol. 2019;93(17). Published online 2019. doi: 10.1128/JVI.00571-19
   PubMed Web of Science ®Google Scholar
• Lam SK. Nipah virus - a potential agent of bioterrorism? Antiviral Res. 2003;57(1–2):113–119. doi: 10.1016/S0166-3542(02)00204-8
   PubMed Web of Science ®Google Scholar
• Li T, Liang Z, Huang W, et al. Pseudotyped virus for henipavirus. Adv Exp Med Biol. 2023;1407:175–190. doi: 10.1007/978-981-99-0113-5_9
   PubMedGoogle Scholar
• Nie J, Liu L, Wang Q, et al. Nipah pseudovirus system enables evaluation of vaccines in vitro and in vivo using non-BSL-4 facilities. Emerg Microbes Infect. 2019;8(1):272–281. doi: 10.1080/22221751.2019.1571871
   PubMed Web of Science ®Google Scholar
• Xu K, Broder CC, Nikolov DB. Ephrin-B2 and ephrin-B3 as functional henipavirus receptors. Semin Cell Dev Biol. 2012;23(1):116–123. doi: 10.1016/J.SEMCDB.2011.12.005
   PubMed Web of Science ®Google Scholar
• Negrete OA, Levroney EL, Aguilar HC, et al. EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus. Nature. 2005;436(7049):401–405. doi: 10.1038/NATURE03838
   PubMed Web of Science ®Google Scholar
• Khetawat D, Broder CC. A functional henipavirus envelope glycoprotein pseudotyped lentivirus assay system. Virol J. 2010;7(1):7. doi: 10.1186/1743-422X-7-312
   PubMedGoogle Scholar
• Bradel-Tretheway BG, Zamora JLR, Stone JA, et al. Nipah and Hendra virus glycoproteins induce comparable homologous but distinct heterologous fusion phenotypes. J Virol. 2019;93(13). doi: 10.1128/jvi.00577-19
   PubMed Web of Science ®Google Scholar
• Yeo YY, Buchholz DW, Gamble A, et al. Headless henipaviral receptor binding glycoproteins reveal fusion modulation by the head/stalk interface and post-receptor binding contributions of the head Domain. J Virol. 2021;95(20). doi: 10.1128/jvi.00666-21
   Web of Science ®Google Scholar
• Liu Q, Stone JA, Bradel-Tretheway B, et al. Unraveling a three-step spatiotemporal mechanism of triggering of receptor-induced Nipah virus fusion and cell entry. PLOS Pathog. 2013;9(11):e1003770. doi: 10.1371/JOURNAL.PPAT.1003770
   PubMed Web of Science ®Google Scholar
• Liu Q, Bradel-Tretheway B, Monreal AI, et al. Nipah virus attachment glycoprotein stalk C-terminal region links receptor binding to fusion triggering. J Virol. 2015;89(3):1838–1850. doi: 10.1128/JVI.02277-14
   PubMed Web of Science ®Google Scholar
• Negrete OA, Chu D, Aguilar HC, et al. Single amino acid changes in the Nipah and Hendra virus attachment glycoproteins distinguish EphrinB2 from EphrinB3 usage. J Virol. 2007;81(19):10804. doi: 10.1128/JVI.00999-07
   PubMed Web of Science ®Google Scholar
• Ang LT, Nguyen AT, Liu KJ, et al. Generating human artery and vein cells from pluripotent stem cells highlights the arterial tropism of Nipah and Hendra viruses. Cell. 2022;185(14):2523–2541.e30. doi: 10.1016/J.CELL.2022.05.024
   PubMed Web of Science ®Google Scholar
• Qiu J. How China’s ‘bat woman’ hunted down viruses from SARS to the new Coronavirus. Scientific American; 2021. doi: 10.1038/scientificamerican0620-24
   Google Scholar
• Wong KT, Shieh WJ, Kumar S, et al. Nipah virus infection: pathology and pathogenesis of an emerging paramyxoviral zoonosis. Am J Pathol. 2002;161(6):2153–2167. doi: 10.1016/S0002-9440(10)64493-8
   PubMed Web of Science ®Google Scholar
• Sazzad HMS, Hossain MJ, Gurley ES, et al. Nipah virus infection outbreak with nosocomial and corpse-to-human transmission, Bangladesh. Emerg Infect Dis. 2013;19(2):210–217. doi: 10.3201/EID1902.120971
   PubMed Web of Science ®Google Scholar
• Borisevich V, Ozdener MH, Malik B, et al. Hendra and Nipah virus infection in cultured human olfactory epithelial cells. mSphere. 2017;2(3). doi: 10.1128/msphere.00252-17
   PubMed Web of Science ®Google Scholar
• Dups J, Middleton D, Long F, et al. Subclinical infection without encephalitis in mice following intranasal exposure to Nipah virus-Malaysia and Nipah virus-Bangladesh. Virol J. 2014;11(1). doi: 10.1186/1743-422X-11-102
   PubMedGoogle Scholar
• Guillaume V, Contamin H, Loth P, et al. Antibody prophylaxis and therapy against Nipah virus infection in hamsters. J Virol. 2006;80(4):1972. doi: 10.1128/JVI.80.4.1972-1978.2006
   PubMed Web of Science ®Google Scholar
• Maisner A, Neufeld J, Weingartl H. Organ- and endotheliotropism of Nipah virus infections in vivo and in vitro. Thromb Haemost. 2009;102(6):1014–1023. doi: 10.1160/TH09-05-0310
   PubMed Web of Science ®Google Scholar
• Stewart CR, Deffrasnes C, Foo CH, et al. A functional genomics approach to henipavirus research: the role of nuclear proteins, MicroRNAs and immune regulators in infection and disease. Curr Top Microbiol Immunol. Vol 419.; 2018. doi: 10.1007/82_2017_28
   Web of Science ®Google Scholar
• Dhondt KP, Mathieu C, Chalons M, et al. Type i interferon signaling protects mice from lethal henipavirus infection. J Infect Dis. 2013;207(1):142–151. doi: 10.1093/infdis/jis653
   PubMed Web of Science ®Google Scholar
• Rodriguez JJ, Horvath CM. Host evasion by emerging paramyxoviruses: Hendra virus and Nipah virus V proteins inhibit interferon signaling. Viral Immunol. 2004;17(2):210–219. doi: 10.1089/0882824041310568
   PubMed Web of Science ®Google Scholar
• Sugai A, Sato H, Takayama I, et al. Nipah and Hendra virus nucleoproteins inhibit nuclear accumulation of signal transducer and activator of transcription 1 (STAT1) and STAT2 by interfering with their complex formation. J Virol. 2017;91(21). doi: 10.1128/jvi.01136-17
   PubMed Web of Science ®Google Scholar
• Keiffer TR, Ciancanelli MJ, Edwards MR, et al. Interactions of the Nipah virus P, V, and W proteins across the STAT family of transcription factors. mSphere. 2020;5(6). doi: 10.1128/msphere.00449-20
   PubMed Web of Science ®Google Scholar
• Bharaj P, Wang YE, Dawes BE, et al. The matrix protein of Nipah virus targets the E3-Ubiquitin Ligase TRIM6 to inhibit the IKKε Kinase-mediated type-I IFN antiviral response. PLOS Pathog. 2016;12(9):e1005880. doi: 10.1371/JOURNAL.PPAT.1005880
   PubMed Web of Science ®Google Scholar
• Parashar UD, Sunn LM, Ong F, et al. Case-control study of risk factors for human infection with a new zoonotic paramyxovirus, Nipah virus, during a 1998-1999 outbreak of severe encephalitis in Malaysia. J Infect Dis. 2000;181(5):1755–1759. doi: 10.1086/315457
   PubMed Web of Science ®Google Scholar
• Enserink M. Nipah Virus (or a Cousin) Strikes Again. Sci (1979). 2004;303(5661):1121–1121. doi: 10.1126/SCIENCE.303.5661.1121B
   Web of Science ®Google Scholar
• Lo MK, Rota PA. The emergence of Nipah virus, a highly pathogenic paramyxovirus. J Clin Virol. 2008;43(4):396–400. doi: 10.1016/J.JCV.2008.08.007
   PubMed Web of Science ®Google Scholar
• Prasad AN, Agans KN, Sivasubramani SK, et al. A lethal aerosol exposure model of Nipah virus strain Bangladesh in African green monkeys. J Infect Dis. 2020;221(Supplement_4):S431–S435. doi: 10.1093/infdis/jiz469
   PubMedGoogle Scholar
• DeBuysscher BL, de Wit E, Munster VJ, et al. Comparison of the pathogenicity of Nipah virus isolates from Bangladesh and Malaysia in the Syrian hamster. PLoS Negl Trop Dis. 2013;7(1):e2024. doi: 10.1371/journal.pntd.0002024
   PubMed Web of Science ®Google Scholar
• Stevens CS, Lowry J, Juelich T, et al. Nipah virus Bangladesh infection elicits organ-specific innate and inflammatory responses in the marmoset model. J Infect Dis. Published online March 3, 2023;228(5):604–614. doi: 10.1093/INFDIS/JIAD053
   PubMedGoogle Scholar
• Mire CE, Satterfield BA, Geisbert JB, et al. Pathogenic differences between Nipah virus Bangladesh and Malaysia strains in primates: implications for antibody therapy. Sci Rep. 2016;6(1):6. doi: 10.1038/SREP30916
   PubMedGoogle Scholar
• Debuysscher BL, Scott DP, Rosenke R, et al. Nipah virus efficiently replicates in human smooth muscle cells without cytopathic effect. Cells. 2021;10(6):1319. doi: 10.3390/CELLS10061319
   PubMed Web of Science ®Google Scholar
• Mathieu C, Pohl C, Szecsi J, et al. Nipah virus uses leukocytes for efficient dissemination within a host. J Virol. 2011;85(15):7863. doi: 10.1128/JVI.00549-11
   PubMed Web of Science ®Google Scholar
• Baseler L, de Wit E, Scott DP, et al. Syrian hamsters (Mesocricetus auratus) oronasally inoculated with a Nipah virus isolate from Bangladesh or Malaysia develop similar respiratory tract lesions. Vet Pathol. 2015;52(1):38–45. doi: 10.1177/0300985814556189
   PubMed Web of Science ®Google Scholar
• Broder CC, Xu K, Nikolov DB, et al. A treatment for and vaccine against the deadly Hendra and Nipah viruses. Antiviral Res. 2013;100(1):8–13. doi: 10.1016/j.antiviral.2013.06.012
   PubMed Web of Science ®Google Scholar
• Woolsey C, Borisevich V, Fears AC, et al. Recombinant vesicular stomatitis virus-vectored vaccine induces long-lasting immunity against Nipah virus disease. J Clin Invest. 2023;133(3). doi: 10.1172/JCI164946
   PubMed Web of Science ®Google Scholar
• Guillaume V, Wong KT, Looi RY, et al. Acute Hendra virus infection: analysis of the pathogenesis and passive antibody protection in the hamster model. Virology. 2009;387(2):459–465. doi: 10.1016/J.VIROL.2009.03.001
   PubMed Web of Science ®Google Scholar
• Playford EG, Munro T, Mahler SM, et al. Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 study. Lancet Infect Dis. 2020;20(4):445–454. doi: 10.1016/S1473-3099(19)30634-6
   PubMed Web of Science ®Google Scholar
• Johnson K, Vu M, Freiberg AN. Recent advances in combating Nipah virus. Fac Rev. 2021;10. doi: 10.12703/R/10-74
   Google Scholar
• Chong HT, Kamarulzaman A, Tan CT, et al. Treatment of acute Nipah encephalitis with ribavirin. Ann Neurol. 2001;49(6):810–813. doi: 10.1002/ANA.1062
   PubMed Web of Science ®Google Scholar
• Wong KT, Grosjean I, Brisson C, et al. A Golden Hamster Model for Human Acute Nipah Virus Infection. Am J Pathol. 2003;163(5):2127–2137. doi: 10.1016/S0002-9440(10)63569-9
   PubMed Web of Science ®Google Scholar
• Mathieu C, Pohl C, Szecsi J, et al. Nipah virus uses leukocytes for efficient dissemination within a host. J Virol. 2011;85(15):7863–7871. doi: 10.1128/jvi.00549-11
   PubMed Web of Science ®Google Scholar
• Looi LM, Chua KB. Lessons from the Nipah virus outbreak in Malaysia. Malays J Pathol. 2007;29(2):63–67.
   PubMedGoogle Scholar
• Goh KJ, Tan CT, Chew NK, et al. Clinical features of Nipah virus encephalitis among pig farmers in Malaysia. N Engl J Med. 2000;342(17):1229–1235. doi: 10.1056/NEJM200004273421701
   PubMed Web of Science ®Google Scholar
• Hansen F, Meade-White K, Clancy C, et al. SARS-CoV-2 reinfection prevents acute respiratory disease in Syrian hamsters but not replication in the upper respiratory tract. Cell Rep. 2022;38(11):110515. doi: 10.1016/J.CELREP.2022.110515
   PubMed Web of Science ®Google Scholar
• Rosenke K, Feldmann F, Okumura A, et al. UK B.1.1.7 (Alpha) variant exhibits increased respiratory replication and shedding in nonhuman primates. Emerg Microbes Infect. 2021;10(1):2173–2182. doi: 10.1080/22221751.2021.1997074
   PubMed Web of Science ®Google Scholar
• Selvey LA, Wells RM, McCormack JG, et al. Infection of humans and horses by a newly described morbillivirus. Med j Aust. 1995;162(12):642–645. doi: 10.5694/J.1326-5377.1995.TB126050.X
   PubMed Web of Science ®Google Scholar
• Wang J, Anderson DE, Halpin K, et al. A new Hendra virus genotype found in Australian flying foxes. Virol J. 2021;18(1). doi: 10.1186/s12985-021-01652-7
   Web of Science ®Google Scholar
• Westbury HA, Hooper PT, Brouwer SL, et al. Susceptibility of cats to equine morbillivirus. Aust Vet J. 1996;74(2):132–134. doi: 10.1111/J.1751-0813.1996.TB14813.X
   PubMed Web of Science ®Google Scholar
• Young PL, Halpin K, Selleck PW, et al. Serologic evidence for the presence in Pteropus bats of a paramyxovirus related to equine morbillivirus. Emerg Infect Dis. 1996;2(3):239–240. doi: 10.3201/EID0203.960315
   PubMed Web of Science ®Google Scholar
• Hall LS. Identification, distribution and taxonomy of Australian flying-foxes (chiroptera: pteropodidae). Aust Mammal. 1987;10(2):75–79. doi: 10.1071/AM87015
   Google Scholar
• DeBuysscher BL, Scott D, Marzi A, et al. Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins. Vaccine. 2014;32(22):2637–2644. doi: 10.1016/j.vaccine.2014.02.087
   PubMed Web of Science ®Google Scholar
• Foster SL, Woolsey C, Borisevich V, et al. A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease. Proc Natl Acad Sci U S A. 2022;119(12). doi: 10.1073/pnas.2200065119
   Web of Science ®Google Scholar
• Mire CE, Geisbert JB, Agans KN, et al. Use of single-injection recombinant vesicular stomatitis virus vaccine to protect nonhuman primates against lethal nipah virus disease. Emerg Infect Dis. 2019;25(6):1144–1152. doi: 10.3201/eid2506.181620
   PubMed Web of Science ®Google Scholar
• O’Donnell KL, Feldmann F, Kaza B, et al. Rapid protection of nonhuman primates against Marburg virus disease using a single low-dose VSV-based vaccine. EBioMedicine. 2023;89. doi: 10.1016/J.EBIOM.2023.104463
   PubMed Web of Science ®Google Scholar
• Taddeo A, Veiga IB, Devisme C, et al. Optimized intramuscular immunization with VSV-vectored spike protein triggers a superior immune response to SARS-CoV-2. NPJ Vaccines. 2022;7(1):1–15. doi: 10.1038/s41541-022-00508-7
   PubMed Web of Science ®Google Scholar
• Fathi A, Dahlke C, Addo MM. Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens. Hum Vaccin Immunother. 2019;15(10):2269. doi: 10.1080/21645515.2019.1649532
   PubMed Web of Science ®Google Scholar
• Ithinji DG, Buchholz DW, Ezzatpour S, et al. Multivalent viral particles elicit safe and efficient immunoprotection against Nipah Hendra and Ebola viruses. NPJ Vaccines. 2022;7(1). doi: 10.1038/S41541-022-00588-5
   PubMed Web of Science ®Google Scholar
• Loomis RJ, DiPiazza AT, Falcone S, et al. Chimeric fusion (F) and attachment (G) glycoprotein antigen delivery by mRNA as a candidate Nipah vaccine. Front Immunol. 2021;12. doi: 10.3389/FIMMU.2021.772864/FULL
   PubMed Web of Science ®Google Scholar
• Arunkumar G, Devadiga S, McElroy AK, et al. Adaptive immune responses in humans during Nipah virus acute and convalescent phases of infection. Clinl Infect Dis. 2019;69(10):1752–1756. doi: 10.1093/cid/ciz010
   PubMed Web of Science ®Google Scholar
• Biering SB, Huang A, Vu AT, et al. N-Glycans on the Nipah virus attachment glycoprotein modulate fusion and viral entry as they protect against antibody neutralization. J Virol. 2012;86(22):11991–12002. doi: 10.1128/jvi.01304-12
   PubMed Web of Science ®Google Scholar
• Freiberg AN, Worthy MN, Lee B, et al. Combined chloroquine and ribavirin treatment does not prevent death in a hamster model of Nipah and Hendra virus infection. J Gen Virol. 2010;91(Pt 3):765. doi: 10.1099/VIR.0.017269-0
   PubMedGoogle Scholar
• Dawes BE, Kalveram B, Ikegami T, et al. Favipiravir (T-705) protects against Nipah virus infection in the hamster model. Sci Rep. 2018;8(1):1–11. doi: 10.1038/s41598-018-25780-3
   PubMedGoogle Scholar